These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1042 related articles for article (PubMed ID: 20373935)
1. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery]. Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa]. Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [TBL] [Abstract][Full Text] [Related]
5. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy. Suprasert P; Srisomboon J; Siriaunkgul S; Khunamornpong S; Phongnarisorn C; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Kietpeerakool C J Med Assoc Thai; 2006 Sep; 89(9):1368-75. PubMed ID: 17100371 [TBL] [Abstract][Full Text] [Related]
7. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348 [TBL] [Abstract][Full Text] [Related]
9. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967 [TBL] [Abstract][Full Text] [Related]
10. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939 [TBL] [Abstract][Full Text] [Related]
11. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy. Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193 [TBL] [Abstract][Full Text] [Related]
12. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion. Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093 [TBL] [Abstract][Full Text] [Related]
14. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863 [TBL] [Abstract][Full Text] [Related]
15. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis. dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872 [TBL] [Abstract][Full Text] [Related]
16. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer. Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955 [TBL] [Abstract][Full Text] [Related]
18. [Risk factors and prognosis of node-positive cervical carcinoma]. Feng SY; Zhang YN; Liu JG Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145 [TBL] [Abstract][Full Text] [Related]
19. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy. Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469 [TBL] [Abstract][Full Text] [Related]
20. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors. Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]